Jim Simons Vista Gen Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.09 - $0.16 $329,181 - $585,211	-3,657,574 Reduced 97.21%	104,800 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.07 $410,446 - $3.14 Million	2,931,762 Added 352.96%	3,762,374 $572,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $306,131 - $601,827	-347,877 Reduced 29.52%	830,612 $731,000
Q1 2022 May 13, 2022	BUY	$1.14 - $2.09 $1.34 Million - $2.46 Million	1,178,489 New	1,178,489 $1.46 Million
Q3 2021 Nov 12, 2021	SELL	$2.62 - $3.45 $268,919 - $354,111	-102,641 Closed	0 $0

Q2 2021 Aug 13, 2021	BUY	$1.96 - $3.15 $201,176 - $323,319	102,641 New	102,641 $323,000
Q1 2021 May 13, 2021	SELL	$1.89 - $2.96 $1.58 Million - $2.47 Million	-834,999 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.65 - $1.94 $462,149 - $1.38 Million	710,999 Added 573.39%	834,999 $1.62 Million
Q3 2020 Nov 13, 2020	BUY	$0.48 - $1.03 $53,784 - $115,411	112,050 Added 937.66%	124,000 $86,000
Q2 2020 Aug 13, 2020	BUY	$0.37 - $0.61 $4,421 - $7,289	11,950 New	11,950 $6,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.